BIOTRONIK Driving the Future of Active Device Business
Company to divest its Vascular Intervention Business Division to Teleflex Inc.
Company to divest its Vascular Intervention Business Division to Teleflex Inc.
Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), a leading provider of isotope technology for medical, scientific, and industrial use, today announced a comprehensive strategic partnership with Bicycle Therapeutics (NASDAQ: BCYC), a pharmaceutical…
In the most competitive financing round to date, the European Innovation Council (EIC) selected a total of 71 companies from 1,211 applications.
A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis. The find paves the way for more personalized…
Application Deadline: March 16th 2024
Latest funding round brings total capital raised to $20.8 million - Federated computing offers transformative approach to unlocking vast datasets held by life science companies - Series A led by DeepTech investors, OTB Ventures and eCAPITAL
The management of the Berlin-based manufacturer of high-tech laboratory instruments reports on current plans to ensure sustainable business success.
Scientists from the Massachusetts Institute of Technology (USA) and Freie Universität combined a mixture of mucilaginous and sticky proteins to produce an adhesive for biomedical applications / Results published in renowned journal PNAS
Deadline: March 31st, 2025
Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech…